These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 914973)

  • 1. Renin reactivity, renin activity and renin concentration in patients with normal and low renin essential hypertension.
    McDonald WJ; Cohen EL; Conn JW
    J Clin Endocrinol Metab; 1977 Oct; 45(4):685-90. PubMed ID: 914973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin reactivity in plasma of patients with normal renin and low renin essential hypertension.
    Brooks CS; Talwalker RT; Kotchen TA
    J Clin Endocrinol Metab; 1977 Feb; 44(2):322-9. PubMed ID: 838842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
    Collins RD; Weinberger MH; Dowdy AJ; Nokes GW; Gonzales CM; Luetscher JA
    J Clin Invest; 1970 Jul; 49(7):1415-26. PubMed ID: 4317384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone regulation in essential hypertension: altered adrenal responsiveness to angiotensin II.
    Williams GH; Dluhy RG; Moore TJ
    Mayo Clin Proc; 1977 May; 52(5):312-6. PubMed ID: 870773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential changes in the renin--angiotensin--aldosterone systems and plasma progesterone concentration in normal and abnormal human pregnancy.
    Weinberger MH; Kramer NJ; Petersen LP; Cleary RE; Young PC
    Perspect Nephrol Hypertens; 1976; 5():263-9. PubMed ID: 1005040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: a case control study.
    Say YH; Ling KH; Duraisamy G; Isaac S; Rosli R
    BMC Cardiovasc Disord; 2005 Apr; 5(1):7. PubMed ID: 15811183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of systemic (essential) hypertension in Zimbabwean hypertensive patients. I. Humoral factors.
    Somova L; Mufunda J; Neil P; Musabayane C
    Cent Afr J Med; 1991 Nov; 37(11):377-83. PubMed ID: 1839614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of renin reactivity by lipids extracted from normal, hypertensive, and uremic plasma.
    Kotchen TA; Talwalker RT; Miller MC; Welch WJ
    J Clin Endocrinol Metab; 1976 Nov; 43(5):971-81. PubMed ID: 186481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II.
    Gahnem F; Camargo MJ; von Lutterotti N; Laragh JH; Sealey JE
    J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A repressive coping style protecting from emotional distress in low-renin essential hypertensives.
    Perini C; Smith DH; Neutel JM; Smith MA; Henry JP; Bühler FR; Weiner H; Weber MA
    J Hypertens; 1994 May; 12(5):601-7. PubMed ID: 7930561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sympathetic and angiotensinergic responses in rats submitted to low- or high-salt diet.
    Carillo BA; Beutel A; Mirandola DA; Vidonho AF; Furukawa LN; Casarini D; Campos RR; Dolnikoff MS; Heimann JC; Bergamaschi CT
    Regul Pept; 2007 Apr; 140(1-2):5-11. PubMed ID: 17196676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of phenylephrine on atrial natriuretic factor and the renin-aldosterone axis in normal patients and essential hypertensive patients].
    Closas J; Genest J; Larochelle P; Cusson J; Gutkowska J; Hamet P; De Léan A; Thibault G; Cantin M
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():75-8. PubMed ID: 2847676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple forms of human plasma renin substrate.
    Eggena P; Hidaka H; Barrett JD; Sambhi MP
    J Clin Invest; 1978 Aug; 62(2):367-72. PubMed ID: 670398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the existence of an acetone soluble renin inhibiting factor in normal human plasma.
    Kotchen TA; Talwalkar RT; Kotchen JM; Miller MC; Welch WJ
    Circ Res; 1975 Jun; 36(6 Suppl 1):17-27. PubMed ID: 1132076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension.
    Chobanian AV; Gavras H; Melby JC; Gavras I; Jick H
    Trans Assoc Am Physicians; 1978; 91():368-80. PubMed ID: 754399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin reactivity in normal, hypertensive, and uremic plasma.
    Kotchen TA; Rice TW; Walters DR
    J Clin Endocrinol Metab; 1972 Jun; 34(6):928-37. PubMed ID: 4336459
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation between renin and prorenin in plasma from hypertensive patients and normal people: evidence for different renin:prorenin ratios.
    Leckie BJ; Morton JJ
    J Hum Hypertens; 1995 Jun; 9(6):493-6. PubMed ID: 7473533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.